New whey protein set to shake up clinical nutrition market

Lacprodan® DI-7017 a ground-breaking whey protein....

A ground-breaking whey protein is set to transform the fast-growing clinical nutrition category by offering companies the opportunity to create a 100% whey based ready-to-drink beverage that is more effective, easier to formulate and better-tasting.

Lacprodan® DI-7017 is a new generation of pure whey protein concentrate that is stable in ultra-high temperature (UHT) formulations at neutral pH, representing a genuine first in the market for clinical nutrition RTD beverages, which was worth almost €4 billion in the US & Europe in 2011.

Whey protein is notoriously hard to incorporate into UHT processes, which are widely used to manufacture clinical nutrition beverages with a long shelf life. As a result, manufacturers have until now tended to use alternative and less nutritionally effective proteins, such as casein, when formulating beverages for use in clinical nutrition. Such beverages are consumed primarily by elderly people suffering with conditions such as sarcopenia (muscle wastage) and patients recovering from illness or surgery.

However, incorporating whey protein into clinical nutrition beverages is highly desirable because there is compelling scientific evidence that whey delivers faster ‘gastric emptying’ and greater levels of muscle synthesis than other protein ingredients.

Read more, please click here.